# Chemed Corp: filings

CHE · NYSE · CIK 19584 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/che.md) · [Financials](/companies/che/financials.md) · [Filings](/companies/che/filings.md) · [Insiders](/companies/che/insiders.md)

## Reports and events: 231 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 861, 8-K 136, SC 13G/A 57, 10-Q 54, 144 41, 5 20, 10-K 18, 11-K 18, DEF 14A 17, UPLOAD 16, 4/A 14, 3 11, DEFA14A 11, SC 13G 10, CORRESP 8, DFAN14A 5, S-8 5, SC 13D/A 3, SCHEDULE 13G 3, DEFC14A 2, PRE 14A 2, PREC14A 2, PRRN14A 2, 10-K/A 1, 11-K/A 1, 3/A 1, 8-K/A 1, ARS 1, DEFR14A 1, NO ACT 1, PX14A6G 1, S-8 POS 1, SC 13D 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 09:00 ET | [10-Q](/filings/0000019584-26-000024.md) | Quarterly report, period 2026-09-30 | 0000019584-26-000024 |
| 2026-10-27 | 16:30 ET | [8-K](/filings/0000019584-26-000022.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000019584-26-000022 |
| 2026-07-31 | 09:04 ET | [10-Q](/filings/0000019584-26-000020.md) | Quarterly report, period 2026-06-30 | 0000019584-26-000020 |
| 2026-07-28 | 16:30 ET | [8-K](/filings/0000019584-26-000018.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000019584-26-000018 |
| 2026-05-19 | 10:43 ET | [8-K](/filings/0000019584-26-000014.md) | 5.07 Shareholder vote results | 0000019584-26-000014 |
| 2026-04-28 | 09:00 ET | [10-Q](/filings/0000019584-26-000012.md) | Quarterly report, period 2026-03-31 | 0000019584-26-000012 |
| 2026-04-23 | 16:30 ET | [8-K](/filings/0000019584-26-000010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000019584-26-000010 |
| 2026-04-13 | 09:03 ET | [8-K](/filings/0000019584-26-000008.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000019584-26-000008 |
| 2026-04-06 | 09:00 ET | [DEF 14A](/filings/0000019584-26-000005.md) | Proxy statement, period 2025-12-31 | 0000019584-26-000005 |
| 2026-02-27 | 09:36 ET | [10-K](/filings/0001562762-26-000020.md) | Annual report, period 2025-12-31 | 0001562762-26-000020 |
| 2026-02-25 | 16:30 ET | [8-K](/filings/0000019584-26-000002.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000019584-26-000002 |
| 2025-10-31 | 09:02 ET | [10-Q](/filings/0000019584-25-000006.md) | Quarterly report, period 2025-09-30 | 0000019584-25-000006 |
| 2025-10-28 | 16:31 ET | [8-K](/filings/0000019584-25-000004.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000019584-25-000004 |
| 2025-07-31 | 09:05 ET | [10-Q](/filings/0001562762-25-000186.md) | Quarterly report, period 2025-06-30 | 0001562762-25-000186 |
| 2025-07-29 | 16:56 ET | [8-K](/filings/0001562762-25-000181.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001562762-25-000181 |
| 2025-06-27 | 16:30 ET | [8-K](/filings/0001562762-25-000164.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001562762-25-000164 |
| 2025-05-20 | 14:00 ET | [8-K](/filings/0001562762-25-000136.md) | 5.07 Shareholder vote results | 0001562762-25-000136 |
| 2025-04-28 | 09:06 ET | [10-Q](/filings/0001562762-25-000096.md) | Quarterly report, period 2025-03-31 | 0001562762-25-000096 |
| 2025-04-23 | 16:30 ET | [8-K](/filings/0001562762-25-000088.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-25-000088 |
| 2025-04-07 | 09:32 ET | [DEF 14A](/filings/0001562762-25-000072.md) | Proxy statement, period 2025-05-19 | 0001562762-25-000072 |
| 2025-04-01 | 09:00 ET | [10-K/A](/filings/0001562762-25-000070.md) | Annual report, amended, period 2024-12-31 | 0001562762-25-000070 |
| 2025-02-28 | 09:01 ET | [10-K](/filings/0001562762-25-000038.md) | Annual report, period 2024-12-31 | 0001562762-25-000038 |
| 2025-02-26 | 16:30 ET | [8-K](/filings/0001562762-25-000032.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-25-000032 |
| 2024-11-01 | 09:00 ET | [10-Q](/filings/0001562762-24-000248.md) | Quarterly report, period 2024-09-30 | 0001562762-24-000248 |
| 2024-10-29 | 16:30 ET | [8-K](/filings/0001562762-24-000241.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-24-000241 |
| 2024-07-26 | 09:01 ET | [10-Q](/filings/0001562762-24-000183.md) | Quarterly report, period 2024-06-30 | 0001562762-24-000183 |
| 2024-07-24 | 16:30 ET | [8-K](/filings/0001562762-24-000179.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-24-000179 |
| 2024-05-21 | 09:01 ET | [8-K](/filings/0001562762-24-000146.md) | 5.07 Shareholder vote results | 0001562762-24-000146 |
| 2024-04-29 | 09:00 ET | [10-Q](/filings/0001562762-24-000106.md) | Quarterly report, period 2024-03-31 | 0001562762-24-000106 |
| 2024-04-24 | 16:16 ET | [8-K](/filings/0001562762-24-000096.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-24-000096 |
| 2024-04-17 | 10:15 ET | [8-K](/filings/0001562762-24-000090.md) | 2.01 Completion of an acquisition or disposition | 0001562762-24-000090 |
| 2024-04-08 | 10:00 ET | [DEF 14A](/filings/0001562762-24-000082.md) | Proxy statement, period 2024-04-08 | 0001562762-24-000082 |
| 2024-03-13 | 09:15 ET | [8-K](/filings/0001562762-24-000053.md) | 8.01 Other events | 0001562762-24-000053 |
| 2024-02-29 | 09:41 ET | [10-K](/filings/0001562762-24-000045.md) | Annual report, period 2023-12-31 | 0001562762-24-000045 |
| 2024-02-27 | 16:33 ET | [8-K](/filings/0001562762-24-000036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-24-000036 |
| 2024-02-01 | 10:00 ET | [8-K](/filings/0001562762-24-000015.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001562762-24-000015 |
| 2023-12-18 | 16:34 ET | [8-K](/filings/0001562762-23-000442.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001562762-23-000442 |
| 2023-11-03 | 16:23 ET | [8-K](/filings/0001562762-23-000398.md) | 5.02 Departure or appointment of officers or directors | 0001562762-23-000398 |
| 2023-10-27 | 09:00 ET | [10-Q](/filings/0001562762-23-000383.md) | Quarterly report, period 2023-09-30 | 0001562762-23-000383 |
| 2023-10-25 | 16:30 ET | [8-K](/filings/0001562762-23-000378.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-23-000378 |
| 2023-07-28 | 09:01 ET | [10-Q](/filings/0001562762-23-000299.md) | Quarterly report, period 2023-06-30 | 0001562762-23-000299 |
| 2023-07-26 | 16:30 ET | [8-K](/filings/0001562762-23-000290.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-23-000290 |
| 2023-05-16 | 11:47 ET | [8-K](/filings/0001562762-23-000250.md) | 5.07 Shareholder vote results | 0001562762-23-000250 |
| 2023-04-28 | 09:29 ET | [10-Q](/filings/0001562762-23-000183.md) | Quarterly report, period 2023-03-31 | 0001562762-23-000183 |
| 2023-04-26 | 16:30 ET | [8-K](/filings/0001562762-23-000174.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-23-000174 |
| 2023-04-06 | 09:00 ET | [DEF 14A](/filings/0001562762-23-000159.md) | Proxy statement | 0001562762-23-000159 |
| 2023-02-27 | 10:14 ET | [10-K](/filings/0001562762-23-000057.md) | Annual report, period 2022-12-31 | 0001562762-23-000057 |
| 2023-02-23 | 16:39 ET | [8-K](/filings/0001562762-23-000053.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-23-000053 |
| 2022-12-09 | 14:12 ET | [8-K](/filings/0001562762-22-000491.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001562762-22-000491 |
| 2022-11-07 | 12:35 ET | [8-K/A](/filings/0001562762-22-000433.md) | 5.02 Departure or appointment of officers or directors | 0001562762-22-000433 |

Page 1 of 5. [Older](/companies/che/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 09:14 ET. No prices; not investment advice.